Thursday, December 7, 2023

Just A Minor Matter...


This "miss" is immaterial to pembrolizumab overall, as this FDA approval already exists, as of October 2023.

Now you know.

Onward -- grinning into the chilly Thursday sunshine. . . .

नमस्ते

No comments: